Priorities
The Biostatistics Facility gives highest priority to development and work on basic-science, translational, therapeutic, and cancer-control / population-science studies having or seeking research funding from the NCI or equivalent funding agencies.
Equally important is our support of UPCI’s clinical trial activities through service on its Protocol Review Committees, Data and Safety Monitoring Committee, and Clinical Research Oversight Committee.
A second tier of priorities involves development and work on investigator-initiated industry-sponsored oncology clinical trials evaluating novel therapeutic agents or treatment modalities.
Other cancer-related work intended for publication in peer-reviewed journals, such as unfunded studies based on meta-analyses, chart reviews, or various databases, is addressed on a time-available basis.
No support for non-UPCI members is provided, except for work being done in direct collaboration with a UPCI member on a cancer-related project.